Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.7.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Income Statement [Abstract]        
Revenues $ 1,621,057 $ 647,440 $ 2,771,776 $ 1,261,896
Cost of revenues 375,711 214,610 846,421 530,840
Gross profit 1,245,346 432,830 1,925,355 731,056
Operating expenses        
Personnel 136,824 118,921 304,686 239,452
Marketing and promotion 45,265 1,598 54,925 4,143
General and administrative 368,557 149,861 591,960 275,025
Depreciation and amortization 93,583 64,247 163,410 99,686
Total expenses 644,229 334,627 1,114,981 618,306
Operating income 601,117 98,203 810,374 112,750
Non-operating expenses 96,312 59,156 196,183 130,311
Net income (loss) 504,805 39,047 614,191 (17,561)
Net income (loss) to non-controlling interest (42,195) 90,033 99,431 128,805
Net income (loss) attributable to MariMed Inc. $ 547,000 $ (50,986) $ 514,760 $ (146,366)
Net income (loss) per share $ 0.008 $ (0.001) $ 0.008 $ (0.003)
Weighted average common shares outstanding 65,593,751 59,509,792 64,912,354 45,890,780